close X

Download Client Registration Documents

Client Registration Documents in Vernacular language
Home FAQ's Sitemap Feedback Download Grievance Careers E-mail Calculator
Market
 
Equity Analysis
  Price
- Gainers & Losers
- Weekly Gainers & Losers
- Monthly Gainers & Losers
- Out & Under Performers
- Only Buyers & Sellers
- Advances & Declines
- New Highs & Lows
- Weightage
- 5 Days Up & Down
  Volume
  Analysis
News Analysis
Corporate Action
Other Market
Company Profile
Derivatives
 
 
Company Background  
Cadila Healthcare Ltd.
 
Industry : Pharmaceuticals & Drugs House : Cadila
BSE Code   532321
ISIN Demat   INE010B01027
Book Value   88.26
NSE Code CADILAHC
Dividend Yield %  1.61
Market Cap   222817.58
P/E   16.26
EPS   13.39
Face Value 1  
 
Incorporation Year 15-05 1995  
Registered Office Formulation Units,Zydus Tower,Satellite Cross Roads, Ahmedabad,
Gujarat-380015 .
ISINNO INE010B01027  
Phone 079- 26868100 /26868101 /26868102 /26868103 / 04 / 05 / 06 / 07 / 08 / 09 / 10 / 11 / 12 / 13 / 14 / 15 / 16 / 17 / 18 / 19 / 20  
E-mail investor.grievance@zyduscadila.com
URL www.zyduscadila.com
Industry Pharmaceuticals & Drugs  
Chairman Pankaj R Patel  
Managing Director Sharvil P Patel  
Company Secretary Dhaval N Soni  
Listing BSE,NSE,MCX  
  Privacy Policy|Disclaimer|Internal Policy & Procedures|Usefull Links
Stock Broking
BNK Securities Pvt Ltd. (ISO 9001:2015 Certified) MEMBERS OF NSE, BSE AND MSEI SEBI Registration No: INZ000220037
SEBI Registration No : MB / INM000011641 (Category I Merchant Banker), Research Analyst. Reg no INH300003520
DEPOSITORY PARTICIPANT SEBI Registration No – IN-DP-CDSL-508-2009, CDSL DP ID – 12060500.
BNK COMMODITIES PVT.LTD. SEBI Registration No INZ000048331
BNK Capital Markets Ltd. (ISO 9001:2015and ISO 27001: 2015 Certified) RBI Registration no: B-05.02574

© 2009 BNK Capitals All Rights Reserved
Designed , Developed & Content Powered Accord Fintech Pvt. Ltd.